Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models
暂无分享,去创建一个
T. Doman | M. Kalos | J. Manro | M. Brahmachary | I. Inigo | Ruslan D. Novosiadly | D. Schaer | B. Pytowski | Yanxia Li | Nelusha Amaladas | Gerald E. Hall | Erik R Rasmussen | Marguerita O'Mahony | Qi Li | Oscar Puig | David A. Schaer | R. Novosiadly